← Back
Data updated: Mar 10, 2026
DECATUR
Oncology
DECATUR is a generic drug manufacturer focused on Oncology. Key products include CHOLINE C-11.
2014
Since
2
Drugs
-
Trials
1
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (0)
Company Info
- First Approval
- 2014-10-21
- Latest
- 2018-03-26
- Applications
- 2